|
Status |
Public on Apr 13, 2020 |
Title |
A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
31619506 |
|
Submission date |
Feb 21, 2019 |
Last update date |
Apr 15, 2020 |
Contact name |
Tiandao Li |
Organization name |
Washington University
|
Street address |
4444 Forest Park Ave
|
City |
St Louis |
State/province |
MO |
ZIP/Postal code |
63108 |
Country |
USA |
|
|
Platforms (2) |
GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (26)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE126894 |
A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer (RNA-Seq) |
GSE126897 |
A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer (ChIP-Seq) |
|
Relations |
BioProject |
PRJNA523611 |